RYTM Stock-Based Compensation
Rhythm Pharmaceuticals Inc · Stock-Based Compensation
RYTM Stock-Based Compensation
Latest reported$110.33Mperiod ending
RYTM TTM Stock-Based Comp ($66.00K → $110.33M)
TTM stock-based compensation
High-resolution chart · PNG
RYTM stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 110,330,000 | |
| 77,055,000 | |
| 66,818,000 | |
| 58,108,000 | |
| 50,299,000 | |
| 44,777,000 | |
| 39,682,000 | |
| 37,800,000 | |
| 35,411,000 | |
| 33,944,000 | |
| 32,553,000 | |
| 29,166,000 | |
| 25,350,000 | |
| 21,596,000 | |
| 19,831,000 | |
| 19,220,000 | |
| 19,692,000 | |
| 20,224,000 | |
| 20,804,000 | |
| 20,385,000 | |
| 19,812,000 | |
| 17,171,000 | |
| 17,455,000 | |
| 16,122,000 | |
| 14,462,000 | |
| 14,706,000 | |
| 11,875,000 | |
| 10,974,000 | |
| 9,832,000 | |
| 8,076,000 | |
| 6,390,000 | |
| 5,076,000 | |
| 4,054,000 | |
| 2,972,000 | |
| 2,278,000 | |
| 1,878,000 | |
| 1,307,000 | |
| 1,150,000 | |
| 1,168,000 | |
| 1,092,000 | |
| 834,000 | |
| 568,500 | |
| 298,000 | |
| 72,000 | |
| 45,000 | |
| 55,500 | |
| 66,000 |